On the public citation graph
An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients
0 signed · 400 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/1097-0142(19950301)75:5<1151::aid-cncr2820750515>3.0.co;2-qopenalex-snapshot
The functional assessment of cancer therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors
inferredcites →https://doi.org/10.1007/bf00435979openalex-snapshot
The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires
inferredcites →https://doi.org/10.1007/s00415-002-0839-5openalex-snapshot
Impact of brain tumour treatment on quality of life
inferredcites →https://doi.org/10.1007/s11060-005-9070-4openalex-snapshot
Retrospective analysis of the efficacy and tolerability of levetiracetam in brain tumor patients
inferredcites →https://doi.org/10.1016/s1470-2045(05)70432-0openalex-snapshot
Health-related quality of life in patients with glioblastoma: a randomised controlled trial
inferredcites →https://doi.org/10.1016/s1470-2045(06)70910-xopenalex-snapshot
Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study
inferredcites →https://doi.org/10.1038/sj.bjc.6603876openalex-snapshot
The prognostic value of health-related quality-of-life data in predicting survival in glioblastoma cancer patients: results from an international randomised phase III EORTC Brain Tumour and Radiation Oncology Groups, and NCIC Clinical Trials Group study
inferredcites →https://doi.org/10.1056/nejmoa043330openalex-snapshot
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
inferredcites →https://doi.org/10.1093/jnci/85.5.365openalex-snapshot
The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
inferredcites →https://doi.org/10.1200/jco.2004.03.025openalex-snapshot
How Accurate Is Clinician Reporting of Chemotherapy Adverse Effects? A Comparison With Patient-Reported Symptoms From the Quality-of-Life Questionnaire C30
inferredcites →https://doi.org/10.1200/jco.2005.04.6078openalex-snapshot
Adjuvant Procarbazine, Lomustine, and Vincristine Improves Progression-Free Survival but Not Overall Survival in Newly Diagnosed Anaplastic Oligodendrogliomas and Oligoastrocytomas: A Randomized European Organisation for Research and Treatment of Cancer Phase III Trial
inferredcites →https://doi.org/10.1200/jco.2007.11.1476openalex-snapshot
Prognostic Value of Health-Related Quality-of-Life Data in Predicting Survival in Patients With Anaplastic Oligodendrogliomas, From a Phase III EORTC Brain Cancer Group Study
inferredcites →https://doi.org/10.1200/jco.2007.12.7514openalex-snapshot
Health-Related Quality of Life in Patients Treated for Anaplastic Oligodendroglioma With Adjuvant Chemotherapy: Results of a European Organisation for Research and Treatment of Cancer Randomized Clinical Trial
inferredcites →https://doi.org/10.1586/14737167.5.6.763openalex-snapshot
Health-related quality of life and symptom research in glioblastoma multiforme patients
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4590911openalex-extracted
High-Dose Chemotherapy and Autologous Stem Cell Transplant in Elderly and Fit PCNSL Patients – The Multicenter MARTA Study
inferred← citeshttps://doi.org/10.1001/jama.2015.16669openalex-snapshot
Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma
inferred← citeshttps://doi.org/10.1001/jama.2017.18718openalex-snapshot
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma
inferred← citeshttps://doi.org/10.1001/jamaneurol.2014.3739openalex-snapshot
Treatment of Elderly Patients With Glioblastoma
inferred← citeshttps://doi.org/10.1001/jamaoncol.2017.5082openalex-snapshot
Influence of Treatment With Tumor-Treating Fields on Health-Related Quality of Life of Patients With Newly Diagnosed Glioblastoma
inferred← citeshttps://doi.org/10.1002/14651858.cd008218.pub4openalex-snapshot
Anti-angiogenic therapy for high-grade glioma
inferred← citeshttps://doi.org/10.1002/14651858.cd009229openalex-snapshot
Early versus delayed radiotherapy for the treatment of low-grade gliomas
inferred← citeshttps://doi.org/10.1002/14651858.cd009229.pub2openalex-snapshot
Early versus delayed postoperative radiotherapy for treatment of low-grade gliomas
inferred← citeshttps://doi.org/10.1002/14651858.cd009229.pub3openalex-snapshot
Early versus delayed postoperative radiotherapy for treatment of low-grade gliomas
inferred← citeshttps://doi.org/10.1002/14651858.cd009319openalex-snapshot
Biopsy versus resection for the management of low-grade gliomas
inferred← citeshttps://doi.org/10.1002/14651858.cd009319.pub2openalex-snapshot
Biopsy versus resection for the management of low-grade gliomas
inferred← citeshttps://doi.org/10.1002/14651858.cd009319.pub3openalex-snapshot
Biopsy versus resection for the management of low-grade gliomas
inferred← citeshttps://doi.org/10.1002/14651858.cd012532openalex-snapshot
Immune checkpoint blockade for glioma
inferred← citeshttps://doi.org/10.1002/14651858.cd012532.pub2openalex-snapshot
Anti-PD-1 and anti-PD-L1 antibodies for glioma
inferred← citeshttps://doi.org/10.1002/14651858.cd012582openalex-snapshot
Interventions to help support caregivers of people with a brain or spinal cord tumour
inferred← citeshttps://doi.org/10.1002/14651858.cd012582.pub2openalex-snapshot
Interventions to help support caregivers of people with a brain or spinal cord tumour
inferred← citeshttps://doi.org/10.1002/14651858.cd013238openalex-snapshot
Anti-epidermal growth factor receptor therapy for glioblastoma in adults
inferred← citeshttps://doi.org/10.1002/14651858.cd013238.pub2openalex-snapshot
Anti-epidermal growth factor receptor therapy for glioblastoma in adults
inferred← citeshttps://doi.org/10.1002/cam4.5512openalex-snapshot
CD79B Y196 mutation is a potent predictive marker for favorable response to R‐MPV in primary central nervous system lymphoma
inferred← citeshttps://doi.org/10.1002/cam4.734openalex-snapshot
Prognostic value of health‐related quality of life for death risk stratification in patients with unresectable glioblastoma
inferred← citeshttps://doi.org/10.1002/cncr.34980openalex-snapshot
Quality of life after surgery for lower grade gliomas
inferred← citeshttps://doi.org/10.1002/epi4.70274openalex-snapshot
Perampanel as add‐on in high‐grade glioma–related epilepsy: Seizure control and QoL in a prospective, multicenter, real‐world 6‐month follow‐up study
inferred← citeshttps://doi.org/10.1002/pon.4906openalex-snapshot
Patient‐reported health‐related quality of life outcomes in supportive‐care interventions for adults with brain tumors: A systematic review
inferred← citeshttps://doi.org/10.1002/pon.5564openalex-snapshot
Towards the targeted assessment of relevant problems: Optimization of the distress Thermometer for adult neuro‐oncological patients
inferred← citeshttps://doi.org/10.1002/pon.5889openalex-snapshot
Is the EORTC QLQ‐C30 emotional functioning scale appropriate as an initial screening measure to identify brain tumour patients who may possibly have a mood disorder?
inferred← citeshttps://doi.org/10.1007/978-1-4471-2213-5_14openalex-snapshot
Quality of Life in Low-Grade Gliomas
inferred← citeshttps://doi.org/10.1007/978-3-030-04152-6_43openalex-snapshot
Quality of Life and Cognition
inferred← citeshttps://doi.org/10.1007/978-3-030-23417-1_29openalex-snapshot
Health-Related Quality of Life Related to Toxicity Treatments in Central Nervous System Metastases
inferred← citeshttps://doi.org/10.1007/978-3-030-23417-1_32openalex-snapshot
Clinical Trials: Endpoints and Outcome Assessment
inferred← citeshttps://doi.org/10.1007/978-3-319-30576-9_9openalex-snapshot
Supportive Care in Patients Using Tumor Treating Fields Therapy
inferred← citeshttps://doi.org/10.1007/978-3-319-69909-7_3395-2openalex-snapshot
EORTC QLQ-30 Modules
inferred← citeshttps://doi.org/10.1007/978-3-319-95684-8_8openalex-snapshot
Neurorehabilitation in Neuro-Oncology
inferred← citeshttps://doi.org/10.1007/978-94-007-2019-0_25openalex-snapshot
Electronic Patient-Reported Outcome Monitoring (ePROM) in Brain Tumour Patients
inferred← citeshttps://doi.org/10.1007/s00066-019-01506-wopenalex-snapshot
Quality of life in patients with limited (1–3) brain metastases undergoing stereotactic or whole brain radiotherapy
inferred← citeshttps://doi.org/10.1007/s00066-022-02024-yopenalex-snapshot
Meningioma WHO I with involvement of the optical structures—does proton therapy lead to changes in quality of life with regard to subjective visual performance?
inferred← citeshttps://doi.org/10.1007/s00381-017-3548-1openalex-snapshot
Quality of life in long-term survivors treated for metastatic medulloblastoma with a hyperfractionated accelerated radiotherapy (HART) strategy
inferred← citeshttps://doi.org/10.1007/s00415-014-7273-3openalex-snapshot
Quality of life and brain tumors: what beyond the clinical burden?
inferred← citeshttps://doi.org/10.1007/s00432-020-03187-wopenalex-snapshot
Proton therapy re-irradiation preserves health-related quality of life in large recurrent glioblastoma
inferred← citeshttps://doi.org/10.1007/s00432-023-05338-1openalex-snapshot
Frequency of social burden and underage children in neuro-oncological patients
inferred← citeshttps://doi.org/10.1007/s00520-013-2058-2openalex-snapshot
Assessment of a brain-tumour-specific Patient Concerns Inventory in the neuro-oncology clinic
inferred← citeshttps://doi.org/10.1007/s00520-014-2352-7openalex-snapshot
Comparison of the EORTC QLQ-BN20 and the FACT-Br quality of life questionnaires for patients with primary brain cancers: a literature review
inferred← citeshttps://doi.org/10.1007/s00520-014-2384-zopenalex-snapshot
Glioblastoma multiforme from diagnosis to death: a prospective, hospital-based, cohort, pilot feasibility study of patient reported symptoms and needs
inferred← citeshttps://doi.org/10.1007/s00520-019-04718-zopenalex-snapshot
Evaluation of the psychological burden during the early disease trajectory in patients with intracranial tumors by the ultra-brief Patient Health Questionnaire for Depression and Anxiety (PHQ-4)
inferred← citeshttps://doi.org/10.1007/s00520-020-05354-8openalex-snapshot
Health-related quality of life and distress in elderly vs. younger patients with high-grade glioma—results of a multicenter study
inferred← citeshttps://doi.org/10.1007/s00520-021-06732-6openalex-snapshot
Preoperative nonmedical predictors of functional impairment after brain tumor surgery
inferred← citeshttps://doi.org/10.1007/s00520-026-11262-0openalex-snapshot
Health-related quality of life and its determinants in patients with malignant brain tumors: a prospective longitudinal study
inferred← citeshttps://doi.org/10.1007/s00701-013-1930-7openalex-snapshot
Predictors of health-related quality of life in neurosurgical brain tumor patients: focus on patient-centered perspective
inferred← citeshttps://doi.org/10.1007/s00701-017-3332-8openalex-snapshot
Health-related quality of life of cranial WHO grade I meningioma patients: are current questionnaires relevant?
inferred← citeshttps://doi.org/10.1007/s00701-020-04488-2openalex-snapshot
Intratumoral retrograde microdialysis treatment of high-grade glioma with cisplatin
inferred← citeshttps://doi.org/10.1007/s00701-026-06922-3openalex-snapshot
Patient-reported headache before and after surgery for pituitary adenomas: a longitudinal single-centre study
inferred← citeshttps://doi.org/10.1007/s10143-017-0836-xopenalex-snapshot
The patients’ view: impact of the extent of resection, intraoperative imaging, and awake surgery on health-related quality of life in high-grade glioma patients—results of a multicenter cross-sectional study
inferred← citeshttps://doi.org/10.1007/s10198-024-01729-4openalex-snapshot
Cancer-specific utility: clinical validation of the EORTC QLU-C10D in patients with glioblastoma
inferred← citeshttps://doi.org/10.1007/s10354-011-0872-zopenalex-snapshot
Computergestütztes Patient-reported Outcome Monitoring in der Neuroonkologie: Lebensqualität und Rezidiv beim Glioblastom
inferred← citeshttps://doi.org/10.1007/s11060-010-0364-9openalex-snapshot
Health-related quality of life and cognitive functioning in adult patients with supratentorial WHO grade II glioma: status prior to therapy
inferred← citeshttps://doi.org/10.1007/s11060-011-0761-8openalex-snapshot
Pilot study on sex hormone levels and fertility in women with malignant gliomas
inferred← citeshttps://doi.org/10.1007/s11060-012-0819-2openalex-snapshot
Methodological issues in designing and reporting health-related quality of life in cancer clinical trials: the challenge of brain cancer studies
inferred← citeshttps://doi.org/10.1007/s11060-012-0897-1openalex-snapshot
Neurocognitive and sociodemographic functioning of glioblastoma long-term survivors
inferred← citeshttps://doi.org/10.1007/s11060-012-1012-3openalex-snapshot
Enhancing quality of life and mastery of informal caregivers of high-grade glioma patients: a randomized controlled trial
inferred← citeshttps://doi.org/10.1007/s11060-013-1099-1openalex-snapshot
Quality of life after stereotactic radiotherapy for meningioma: a prospective non-randomized study
inferred← citeshttps://doi.org/10.1007/s11060-013-1198-zopenalex-snapshot
Health-related quality of life of significant others of patients with malignant CNS versus non-CNS tumors: a comparative study
inferred← citeshttps://doi.org/10.1007/s11060-014-1673-1openalex-snapshot
Health related quality of life (HRQOL) in long-term survivors of pediatric low grade gliomas (LGGs)
inferred← citeshttps://doi.org/10.1007/s11060-016-2280-0openalex-snapshot
Evaluating patients for psychosocial distress and supportive care needs based on health-related quality of life in primary brain tumors: a prospective multicenter analysis of patients with gliomas in an outpatient setting
inferred← citeshttps://doi.org/10.1007/s11060-017-2479-8openalex-snapshot
Health-related quality of life outcomes from CABARET: a randomized phase 2 trial of carboplatin and bevacizumab in recurrent glioblastoma
inferred← citeshttps://doi.org/10.1007/s11060-017-2484-yopenalex-snapshot
Factors associated with supportive care needs in glioma patients in the neuro-oncological outpatient setting
inferred← citeshttps://doi.org/10.1007/s11060-017-2601-yopenalex-snapshot
Health-related quality of life, cognitive screening, and functional status in a randomized phase III trial (EF-14) of tumor treating fields with temozolomide compared to temozolomide alone in newly diagnosed glioblastoma
inferred← citeshttps://doi.org/10.1007/s11060-017-2712-5openalex-snapshot
Internet-based guided self-help for glioma patients with depressive symptoms: a randomized controlled trial
inferred← citeshttps://doi.org/10.1007/s11060-020-03414-xopenalex-snapshot
Prospective memory and brain metastases: a relevant target for rehabilitation in post-operative patients?
inferred← citeshttps://doi.org/10.1007/s11060-020-03454-3openalex-snapshot
Healthcare utilization and productivity loss in glioma patients and family caregivers: the impact of treatable psychological symptoms
inferred← citeshttps://doi.org/10.1007/s11060-020-03502-yopenalex-snapshot
Neurocognitive functioning and health-related quality of life in adult medulloblastoma patients: long-term outcomes of the NOA-07 study
inferred← citeshttps://doi.org/10.1007/s11060-020-03587-5openalex-snapshot
Complete response to therapy: why do primary central nervous system lymphoma patients not return to work?
inferred← citeshttps://doi.org/10.1007/s11060-021-03895-4openalex-snapshot
Reforming support systems of newly diagnosed brain cancer patients: a systematic review
inferred← citeshttps://doi.org/10.1007/s11060-022-04198-yopenalex-snapshot
Quality of life outcomes in incidental and operated meningiomas (QUALMS): a cross-sectional cohort study
inferred← citeshttps://doi.org/10.1007/s11060-022-04208-zopenalex-snapshot
Long term quality of life outcomes following surgical resection alone for benign paediatric intracranial tumours
inferred← citeshttps://doi.org/10.1007/s11060-023-04303-9openalex-snapshot
Remote assessment of cognition and quality of life following radiotherapy for glioma: deep-learning-based predictive models and MRI correlates
inferred← citeshttps://doi.org/10.1007/s11060-024-04646-xopenalex-snapshot
Health-related quality of life and neurocognitive functioning in patients with recurrent glioblastoma treated with intracerebral immune checkpoint inhibition
inferred← citeshttps://doi.org/10.1007/s11060-024-04693-4openalex-snapshot
Long term follow-up of patients with newly diagnosed glioblastoma treated by intraoperative photodynamic therapy: an update from the INDYGO trial (NCT03048240)
inferred← citeshttps://doi.org/10.1007/s11060-024-04817-wopenalex-snapshot
Sexual dysfunction after surgery for primary sporadic cranial meningiomas: prevalence and risk factors
inferred← citeshttps://doi.org/10.1007/s11060-024-04888-9openalex-snapshot
Health-related quality of life in 62 patients with diffuse low-grade glioma during a non-therapeutic and progression-free phase: a cross-sectional study
inferred← citeshttps://doi.org/10.1007/s11060-025-05223-6openalex-snapshot
Physician-led versus questionnaire-based psychosocial screening in adults with high-grade glioma: a cluster-randomized controlled trial (GLIOPT)
inferred← citeshttps://doi.org/10.1007/s11060-025-05250-3openalex-snapshot
Autonomy duration in patients with biopsy-only unresectable IDH wild-type glioblastomas
inferred← citeshttps://doi.org/10.1007/s11060-025-05333-1openalex-snapshot
China National Glioma Registry (CNGR): protocol for a prospective observational registry study
inferred← citeshttps://doi.org/10.1007/s11060-025-05419-wopenalex-snapshot
Patient-reported outcomes as prognostic indicators for overall survival and progression-free survival in brain tumor patients – a systematic review and meta-analysis of randomized clinical trials
inferred← citeshttps://doi.org/10.1007/s11060-026-05631-2openalex-snapshot
Health-related quality-of-life of WHO grade 4 astrocytoma patients receiving alternating electrical field therapy: a prospective real-world multi-centre study
inferred← citeshttps://doi.org/10.1007/s11060-026-05649-6openalex-snapshot
Intraoperative radiotherapy after resection of newly diagnosed brain metastases in adult patients - results of a prospective phase II trial (INTRAMET)
inferred← citeshttps://doi.org/10.1007/s11060-026-05767-1openalex-snapshot
Five-year changes in health-related quality of life after proton therapy in a primarily meningioma cohort: a prospective study
inferred← citeshttps://doi.org/10.1007/s11136-013-0511-9openalex-snapshot
The EORTC QLQ-C15-PAL questionnaire: validation study for Spanish bone metastases patients
inferred← citeshttps://doi.org/10.1007/s11136-014-0730-8openalex-snapshot
Longitudinal quality of life data: a comparison of continuous and ordinal approaches
inferred← citeshttps://doi.org/10.1007/s11136-022-03207-xopenalex-snapshot
Health-related quality of life in adults with low-grade gliomas: a systematic review
inferred← citeshttps://doi.org/10.1007/s11136-025-04029-3openalex-snapshot
Challenges in interpreting individual-level changes in health-related quality of life in patients with glioma using minimally important differences (MIDs) and a 4-point Likert scale
inferred← citeshttps://doi.org/10.1007/s11764-023-01355-8openalex-snapshot
Symptom networks in glioma patients: understanding the multidimensionality of symptoms and quality of life
inferred← citeshttps://doi.org/10.1007/s11864-026-01392-2openalex-snapshot
Addressing Unmet Needs in the Management of Small Cell Lung Cancer: Treatment of Brain Metastases, Quality of Life, and the Role of Real-World Evidence
inferred← citeshttps://doi.org/10.1007/s11910-013-0359-yopenalex-snapshot
Health-related Quality of Life in Patients with Brain Tumors: Limitations and Additional Outcome Measures
inferred← citeshttps://doi.org/10.1007/s11912-012-0276-2openalex-snapshot
Measuring Clinical Benefit: Use of Patient-Reported Outcomes (PRO) in Primary Brain Tumor Clinical Trials
inferred← citeshttps://doi.org/10.1007/s12094-017-1703-5openalex-snapshot
Quality of life after whole brain radiotherapy compared with radiosurgery of the tumor bed: results from a randomized trial
inferred← citeshttps://doi.org/10.1007/s13566-012-0016-0openalex-snapshot
Quality of life in patients with brain metastases using the EORTC QLQ-BN20 and QLQ-C30
inferred← citeshttps://doi.org/10.1007/s13566-012-0044-9openalex-snapshot
Content validation of the EORTC QLQ-BN20+2 with patients and health care professionals to assess quality of life in brain metastases
inferred← citeshttps://doi.org/10.1016/b978-0-12-805299-0.00062-2openalex-snapshot
Quality of Life and Health-Related Issues
inferred← citeshttps://doi.org/10.1016/b978-0-12-812100-9.00061-9openalex-snapshot
Quality of Life in Neuro-Oncology
inferred← citeshttps://doi.org/10.1016/b978-0-323-95702-1.00489-9openalex-snapshot
Neuro-Oncology: General Introduction
inferred← citeshttps://doi.org/10.1016/b978-0-323-95702-1.00498-xopenalex-snapshot
Health-Related Quality of Life in Neuro-Oncology
inferred← citeshttps://doi.org/10.1016/b978-0-443-15663-2.00040-7openalex-snapshot
Quality of life and patient-reported outcomes in neuro-oncology clinical care and research
inferred← citeshttps://doi.org/10.1016/b978-0-443-27356-8.00022-xopenalex-snapshot
Quality of life in neuro-oncology
inferred← citeshttps://doi.org/10.1016/b978-0-444-52138-5.00014-1openalex-snapshot
Evaluation of cognitive functions and quality of life
inferred← citeshttps://doi.org/10.1016/j.annonc.2020.04.014openalex-snapshot
Health-related quality of life after chemotherapy with or without rituximab in primary central nervous system lymphoma patients: results from a randomised phase III study
inferred← citeshttps://doi.org/10.1016/j.bas.2024.102818openalex-snapshot
Incidence, risk factors, and clinical implications of postoperative blood in or near the resection cavity after glioma surgery
inferred← citeshttps://doi.org/10.1016/j.canrad.2015.05.012openalex-snapshot
Radiothérapie des gliomes chez l’adulte : quels sont les enjeux de la surveillance ?
inferred← citeshttps://doi.org/10.1016/j.canrad.2022.10.004openalex-snapshot
Health-related quality of life and cognitive failures in patients with lower-grade gliomas treated with radiotherapy
inferred← citeshttps://doi.org/10.1016/j.clineuro.2018.03.026openalex-snapshot
Improvement of health related quality of life in patients with recurrent glioma treated with bevacizumab plus daily temozolomide as the salvage therapy
inferred← citeshttps://doi.org/10.1016/j.clon.2019.09.049openalex-snapshot
Patient Involvement in the Design of a Randomised Trial of Proton Beam Radiotherapy Versus Standard Radiotherapy for Good Prognosis Glioma
inferred← citeshttps://doi.org/10.1016/j.clon.2020.06.003openalex-snapshot
Lapatinib plus Capecitabine versus Trastuzumab plus Capecitabine in the Treatment of Human Epidermal Growth Factor Receptor 2-positive Metastatic Breast Cancer with Central Nervous System Metastases for Patients Currently or Previously Treated with Trastuzumab (LANTERN): a Phase II Randomised Trial
inferred← citeshttps://doi.org/10.1016/j.ctro.2023.100597openalex-snapshot
Longitudinal trajectory of quality of life for patients with melanoma brain metastases: A secondary analysis from a whole brain radiotherapy randomized clinical trial
inferred← citeshttps://doi.org/10.1016/j.ctro.2023.100620openalex-snapshot
Prospective Pilot study of Quality of Life in patients with severe late-radiation-toxicity treated by Low hyperbaric-oxigen-therapy
inferred← citeshttps://doi.org/10.1016/j.ctro.2024.100798openalex-snapshot
Preoperative radiosurgery for brain metastases (PREOP-1): A feasibility trial
inferred← citeshttps://doi.org/10.1016/j.ctro.2025.100929openalex-snapshot
The effect of radiation dose to the brain on early self-reported cognitive function in brain and head-and-neck cancer patients
inferred← citeshttps://doi.org/10.1016/j.ejca.2011.11.010openalex-snapshot
Decision-making in the end-of-life phase of high-grade glioma patients
inferred← citeshttps://doi.org/10.1016/j.ejca.2015.03.025openalex-snapshot
The impact of bevacizumab on health-related quality of life in patients treated for recurrent glioblastoma: Results of the randomised controlled phase 2 BELOB trial
inferred← citeshttps://doi.org/10.1016/j.ejca.2018.02.032openalex-snapshot
Phase I feasibility study for intrathecal administration of trastuzumab in patients with HER2 positive breast carcinomatous meningitis
inferred← citeshttps://doi.org/10.1016/j.ejca.2019.05.012openalex-snapshot
The added value of health-related quality of life as a prognostic indicator of overall survival and progression-free survival in glioma patients: a meta-analysis based on individual patient data from randomised controlled trials
inferred← citeshttps://doi.org/10.1016/j.ejca.2021.01.010openalex-snapshot
Impact of depatuxizumab mafodotin on health-related quality of life and neurological functioning in the phase II EORTC 1410/INTELLANCE 2 trial for EGFR-amplified recurrent glioblastoma
inferred← citeshttps://doi.org/10.1016/j.ejca.2021.06.055openalex-snapshot
Patient-reported outcomes in a phase II randomised study of regorafenib compared with lomustine in patients with relapsed glioblastoma (the REGOMA trial)
inferred← citeshttps://doi.org/10.1016/j.ejca.2023.112946openalex-snapshot
Health-related quality-of-life results from the randomised phase II TAVAREC trial on temozolomide with or without bevacizumab in 1p/19q intact first-recurrence World Health Organization grade 2 and 3 glioma (European Organization for Research and Treatment of Cancer 26091)
inferred← citeshttps://doi.org/10.1016/j.ejon.2026.103215openalex-snapshot
Five years On: Lasting impact of proton therapy on health-related quality of life in brain tumor survivors
inferred← citeshttps://doi.org/10.1016/j.eplepsyres.2024.107310openalex-snapshot
Clinical outcome assessment in patients with epilepsy: The value of health-related quality of life measurements
inferred← citeshttps://doi.org/10.1016/j.esmoop.2024.102943openalex-snapshot
REGOMA-OSS: a large, Italian, multicenter, prospective, observational study evaluating the efficacy and safety of regorafenib in patients with recurrent glioblastoma
inferred← citeshttps://doi.org/10.1016/j.esmorw.2026.100776openalex-snapshot
Development of a patient-reported outcomes registry for patients with brain tumours (BEACON)
inferred← citeshttps://doi.org/10.1016/j.heliyon.2023.e13278openalex-snapshot
Frequency and burden of potentially treatable symptoms in glioma patients with stable disease
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2011.01.068openalex-snapshot
Diffusion Tensor Imaging of Normal-Appearing White Matter as Biomarker for Radiation-Induced Late Delayed Cognitive Decline
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2011.09.025openalex-snapshot
Quality of Life in Patients With Brain Metastases Using the EORTC QLQ-BN20+2 and QLQ-C15-PAL
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2013.02.013openalex-snapshot
Health-Related Quality of Life in Elderly Patients With Newly Diagnosed Glioblastoma Treated With Short-Course Radiation Therapy Plus Concomitant and Adjuvant Temozolomide
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2017.01.242openalex-snapshot
Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With 5-mm Margins With Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma: Health-Related Quality of Life Results
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2019.01.003openalex-snapshot
Impact of Radiation Target Volume on Health-Related Quality of Life in Patients With Low-Grade Glioma in the 2-Year Period Post Treatment: A Secondary Analysis of the EORTC 22033-26033
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2021.01.033openalex-snapshot
A Phase 2 Study of Dose-intensified Chemoradiation Using Biologically Based Target Volume Definition in Patients With Newly Diagnosed Glioblastoma
inferred← citeshttps://doi.org/10.1016/j.inat.2021.101339openalex-snapshot
Health-related quality of life of glioblastoma patients receiving post-operative concomitant chemoradiotherapy plus adjuvant chemotherapy: A longitudinal study
inferred← citeshttps://doi.org/10.1016/j.jocn.2013.11.027openalex-snapshot
Surgical strategies in low-grade gliomas and implications for long-term quality of life
inferred← citeshttps://doi.org/10.1016/j.jocn.2016.03.006openalex-snapshot
Symptom resolution in infiltrating WHO grade II-IV glioma patients undergoing surgical resection
inferred← citeshttps://doi.org/10.1016/j.jocn.2018.04.034openalex-snapshot
Patient reported feasibility and acceptance of Montreal Cognitive Assessment (MoCA) screening pre- and postoperatively in brain tumour patients
inferred← citeshttps://doi.org/10.1016/j.jocn.2024.01.018openalex-snapshot
Effect of low-dose bevacizumab on health-related quality of life in patients with recurrent high-grade glioma: A retrospective clinical study
inferred← citeshttps://doi.org/10.1016/j.jsampl.2024.100059openalex-snapshot
Exercise as a non-pharmacological intervention for the management of sleep disturbance in primary brain tumour survivors and their caregivers: A study protocol of a clinical trial
inferred← citeshttps://doi.org/10.1016/j.jval.2013.11.006openalex-snapshot
Development of a Symptom Index for Patients with Primary Brain Tumors
inferred← citeshttps://doi.org/10.1016/j.lana.2023.100584openalex-snapshot
Untoward global effects of current guideline formulation of stereotactic radiotherapy for symptomatic brain metastases by international medical societies
inferred← citeshttps://doi.org/10.1016/j.lungcan.2017.07.033openalex-snapshot
Prospective analysis of patient reported symptoms and quality of life in patients with incurable lung cancer treated in a rapid access clinic
inferred← citeshttps://doi.org/10.1016/j.neucie.2025.500741openalex-snapshot
Early postoperative quality of life in glioma patients – A prospective cohort study
inferred← citeshttps://doi.org/10.1016/j.neucir.2025.500741openalex-snapshot
Calidad de vida posoperatoria temprana en pacientes con glioma: un estudio de cohorte prospectivo
inferred← citeshttps://doi.org/10.1016/j.neurol.2026.01.005openalex-snapshot
Early onset radiation-induced leukoencephalopathy in patients treated for a glioblastoma by STUPP protocol and risk factors evaluation, an ancillary study of the phase III ASTER protocol
inferred← citeshttps://doi.org/10.1016/j.radonc.2019.12.024openalex-snapshot
Neurocognitive function and quality of life after proton beam therapy for brain tumour patients
inferred← citeshttps://doi.org/10.1016/j.radonc.2024.110582openalex-snapshot
Patient reported fatigue after proton therapy for malignant brain tumours – Is there a relation between radiation dose and brain structures?
inferred← citeshttps://doi.org/10.1016/j.rare.2023.100012openalex-snapshot
Measuring health-related quality of life in solid rare cancer patients: A study protocol
inferred← citeshttps://doi.org/10.1016/j.tipsro.2021.01.004openalex-snapshot
Health-related quality of life in patients with primary brain tumors during and three months after treatment with proton beam therapy
inferred← citeshttps://doi.org/10.1016/j.wneu.2017.02.061openalex-snapshot
Therapy for Recurrent High-Grade Gliomas: Results of a Prospective Multicenter Study on Health-Related Quality of Life
inferred← citeshttps://doi.org/10.1016/j.wneu.2022.05.038openalex-snapshot
Quality of Life in Craniopharyngioma: A Systematic Review
inferred← citeshttps://doi.org/10.1016/j.wneu.2023.08.115openalex-snapshot
Cognition, Emotional States and Health-Related Quality of Life in Awake Craniotomy for Glioma: A Case Series
inferred← citeshttps://doi.org/10.1016/s0140-6736(16)30825-xopenalex-snapshot
Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial
inferred← citeshttps://doi.org/10.1016/s1470-2045(11)70057-2openalex-snapshot
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas
inferred← citeshttps://doi.org/10.1016/s1470-2045(13)70308-5openalex-snapshot
Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO group
inferred← citeshttps://doi.org/10.1016/s1470-2045(16)30305-9openalex-snapshot
Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study
inferred← citeshttps://doi.org/10.1016/s1470-2045(18)30004-4openalex-snapshot
Working plan for the use of patient-reported outcome measures in adults with brain tumours: a Response Assessment in Neuro-Oncology (RANO) initiative
inferred← citeshttps://doi.org/10.1016/s1470-2045(19)30502-9openalex-snapshot
Health-related quality of life and neurocognitive functioning with lomustine–temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial
inferred← citeshttps://doi.org/10.1016/s1470-2045(24)00585-0openalex-snapshot
Short-course hypofractionated proton beam therapy, incorporating 18F-DOPA PET and contrast-enhanced MRI targeting, for patients aged 65 years and older with newly diagnosed glioblastoma: a single-arm phase 2 trial
inferred← citeshttps://doi.org/10.1016/s1470-2045(25)00532-7openalex-snapshot
A comprehensive framework for glioma surgery by the PIONEER Consortium and RANO resect group, part 2: perioperative recommendations for neurological, language, functional, and quality-of-life assessment
inferred← citeshttps://doi.org/10.1016/s2352-3026(23)00371-xopenalex-snapshot
High-dose chemotherapy and autologous haematopoietic stem-cell transplantation in older, fit patients with primary diffuse large B-cell CNS lymphoma (MARTA): a single-arm, phase 2 trial
inferred← citeshttps://doi.org/10.1056/nejmoa1308345openalex-snapshot
Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
inferred← citeshttps://doi.org/10.1056/nejmoa1707358openalex-snapshot
Lomustine and Bevacizumab in Progressive Glioblastoma
inferred← citeshttps://doi.org/10.1080/00207233.2024.2417630openalex-snapshot
Assessing quality of life in Moroccan patients with brain cancer: validation of the Moroccan version of the EORTC QLQ-BN20 questionnaire
inferred← citeshttps://doi.org/10.1080/02687038.2022.2145844openalex-snapshot
Brain Lesions Associated with Communication-Related Quality of Life Following Surgical Removal of Primary Left-Hemisphere Tumours
inferred← citeshttps://doi.org/10.1080/02688697.2019.1698011openalex-snapshot
Does preoperative health-related quality of life predict survival in high-grade glioma patients? – a prospective study
inferred← citeshttps://doi.org/10.1080/09638288.2017.1295472openalex-snapshot
A 12-week interdisciplinary rehabilitation trial in patients with gliomas – a feasibility study
inferred← citeshttps://doi.org/10.1080/09638288.2019.1668486openalex-snapshot
Hemispheric tumor location and the impact on health-related quality of life, symptomatology, and functional performance outcomes in patients with glioma: an exploratory cross-sectional study
inferred← citeshttps://doi.org/10.1080/13548506.2016.1210176openalex-snapshot
Hidden reality: sexual sphere in brain tumor patients
inferred← citeshttps://doi.org/10.1080/15384047.2025.2603095openalex-snapshot
Assessing progesterone receptor modulation in glioblastoma: from in vitro and animal model to a human pilot protocol
inferred← citeshttps://doi.org/10.1080/17434440.2025.2521399openalex-snapshot
Response to letter to the editor on ‘the potential power of Neuralink – how brain-machine interfaces can revolutionize medicine’
inferred← citeshttps://doi.org/10.1080/23279095.2018.1450750openalex-snapshot
Preoperative verbal memory problems and their clinical prognostic value in meningioma patients: A prospective study
inferred← citeshttps://doi.org/10.1080/23809000.2016.1136793openalex-snapshot
Health-related quality of life in brain tumor patients: as an endpoint in clinical trials and its value in clinical care
inferred← citeshttps://doi.org/10.1080/23809000.2016.1140556openalex-snapshot
Neurocognition and quality-of-life in brain metastasis patients who have been irradiated focally or comprehensively
inferred← citeshttps://doi.org/10.1080/28352610.2024.2407120openalex-snapshot
Efficacy of a brief mindfulness-based intervention for brain tumor survivors experiencing depressive symptoms: a pilot study
inferred← citeshttps://doi.org/10.1093/braincomms/fcae241openalex-snapshot
The STELLAR trial: a phase II/III randomized trial of high-dose, intermittent sunitinib in patients with recurrent glioblastoma
inferred← citeshttps://doi.org/10.1093/jjco/hyaa068openalex-snapshot
Factors associated with health-related quality of life in patients with glioma: impact of symptoms and implications for rehabilitation
inferred← citeshttps://doi.org/10.1093/jjco/hyv115openalex-snapshot
Health-related quality of life in long-term survivors with Grade II gliomas: the contribution of disease recurrence and Karnofsky Performance Status
inferred← citeshttps://doi.org/10.1093/neuonc/noab037openalex-snapshot
Establishing anchor-based minimally important differences for the EORTC QLQ-C30 in glioma patients
inferred← citeshttps://doi.org/10.1093/neuonc/noab040openalex-snapshot
A prospective phase II randomized trial of proton radiotherapy vs intensity-modulated radiotherapy for patients with newly diagnosed glioblastoma
inferred← citeshttps://doi.org/10.1093/neuonc/noab111openalex-snapshot
A randomized phase II trial of veliparib, radiotherapy, and temozolomide in patients with unmethylated MGMT glioblastoma: the VERTU study
inferred← citeshttps://doi.org/10.1093/neuonc/noac097openalex-snapshot
Factors associated with health-related quality of life (HRQoL) deterioration in glioma patients during the progression-free survival period
inferred← citeshttps://doi.org/10.1093/neuonc/noac185openalex-snapshot
Long-term wellbeing and neurocognitive functioning of diffuse low-grade glioma patients and their caregivers: A longitudinal study spanning two decades
inferred← citeshttps://doi.org/10.1093/neuonc/noac218openalex-snapshot
Does increase of symptoms mean progression?
inferred← citeshttps://doi.org/10.1093/neuonc/noad224openalex-snapshot
Survival, neurocognitive function, and health-related quality of life outcomes after rituximab—methotrexate, BCNU, teniposide, and prednisolone for primary CNS lymphoma: Final results of the HOVON 105/ALLG NHL 24 study
inferred← citeshttps://doi.org/10.1093/neuonc/noae174openalex-snapshot
Sleep disorders associated with cranial radiation—A systematic review
inferred← citeshttps://doi.org/10.1093/neuonc/noaf172openalex-snapshot
Health-related quality of life and cognitive functioning in survivors of oligodendroglioma: An international cross-sectional investigation
inferred← citeshttps://doi.org/10.1093/neuonc/nos205openalex-snapshot
Factors influencing quality of life in adult patients with primary brain tumors
inferred← citeshttps://doi.org/10.1093/neuonc/not161openalex-snapshot
A single-arm phase II Austrian/German multicenter trial on continuous daily sunitinib in primary glioblastoma at first recurrence (SURGE 01-07)
inferred← citeshttps://doi.org/10.1093/neuonc/nov267openalex-snapshot
Determining priority signs and symptoms for use as clinical outcomes assessments in trials including patients with malignant gliomas: Panel 1 Report
inferred← citeshttps://doi.org/10.1093/neuonc/nov270openalex-snapshot
Report of the Jumpstarting Brain Tumor Drug Development Coalition and FDA clinical trials clinical outcome assessment endpoints workshop (October 15, 2014, Bethesda MD)
inferred← citeshttps://doi.org/10.1093/neuonc/nov291openalex-snapshot
Clinical outcome assessment in malignant glioma trials: measuring signs, symptoms, and functional limitations
inferred← citeshttps://doi.org/10.1093/neuonc/nov326openalex-snapshot
Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma—results from the DIRECTOR trial
inferred← citeshttps://doi.org/10.1093/neuonc/now107openalex-snapshot
Reporting of patient-reported health-related quality of life in adults with diffuse low-grade glioma: a systematic review
inferred← citeshttps://doi.org/10.1093/neuonc/now119openalex-snapshot
Sleep-wake disturbance in patients with brain tumors
inferred← citeshttps://doi.org/10.1093/neuonc/now182openalex-snapshot
Tumor treating fields: a novel treatment modality and its use in brain tumors
inferred← citeshttps://doi.org/10.1093/neuonc/now250openalex-snapshot
Impaired health-related quality of life in meningioma patients—a systematic review
inferred← citeshttps://doi.org/10.1093/neuonc/nox204openalex-snapshot
Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma
inferred← citeshttps://doi.org/10.1093/neuonc/noy152openalex-snapshot
Life after surgical resection of a meningioma: a prospective cross-sectional study evaluating health-related quality of life
inferred← citeshttps://doi.org/10.1093/neuonc/noz118openalex-snapshot
Symptom clusters in newly diagnosed glioma patients: which symptom clusters are independently associated with functioning and global health status?
showing the first 200 of 385 · page through all 385
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.